36732296|t|Tau-RNA complexes inhibit microtubule polymerization and drive disease-relevant conformation change.
36732296|a|Alzheimer's disease and related disorders feature neurofibrillary tangles and other neuropathological lesions composed of detergent-insoluble tau protein. In recent structural biology studies of tau proteinopathy, aggregated tau forms a distinct set of conformational variants specific to the different types of tauopathy disorders. However, the constituents driving the formation of distinct pathological tau conformations on pathway to tau-mediated neurodegeneration remain unknown. Previous work demonstrated RNA can serve as a driver of tau aggregation, and RNA associates with tau containing lesions, but tools for evaluating tau/RNA interactions remain limited. Here we employ molecular interaction studies to measure the impact of tau/RNA binding on tau microtubule binding and aggregation. To investigate the importance of tau/RNA complexes (TRCs) in neurodegenerative disease, we raised a monoclonal antibody (mAb TRC35) against aggregated tau/RNA complexes. Here we show native tau binds RNA with high affinity but low specificity, and tau binding to RNA competes with tau mediated microtubule assembly functions. Tau/RNA interaction in vitro promotes the formation of higher molecular weight tau/RNA complexes which represent an oligomeric tau species. Co-expression of tau and poly(A)45 RNA transgenes in Caenorhabditis elegans exacerbates tau related phenotypes including neuronal dysfunction and pathological tau accumulation. TRC35 exhibits specificity for Alzheimer's disease-derived detergent insoluble tau relative to soluble recombinant tau. Immunostaining with TRC35 labels a wide variety of pathological tau lesions in animal models of tauopathy, which are reduced in mice lacking the RNA binding protein MSUT2. TRC-positive lesions are evident in many human tauopathies including Alzheimer's disease, progressive supranuclear palsy, corticobasal degeneration, and Pick's disease. We also identify ocular pharyngeal muscular dystrophy as a novel tauopathy disorder where loss of function in the poly(A) RNA binding protein (PABPN1) causes accumulation of pathological tau in tissue from postmortem human brain. Tau/RNA binding drives tau conformational change and aggregation inhibiting tau mediated microtubule assembly. Our findings implicate cellular tau/RNA interactions as modulators of both normal tau function and pathological tau toxicity in tauopathy disorders, and suggest feasibility for novel therapeutic approaches targeting TRCs.
36732296	0	3	Tau	Gene	4137
36732296	101	120	Alzheimer's disease	Disease	MESH:D000544
36732296	151	174	neurofibrillary tangles	Disease	MESH:D055956
36732296	185	210	neuropathological lesions	Disease	MESH:D004194
36732296	243	246	tau	Gene	4137
36732296	296	313	tau proteinopathy	Disease	MESH:D057165
36732296	326	329	tau	Gene	4137
36732296	413	432	tauopathy disorders	Disease	MESH:D024801
36732296	507	510	tau	Gene	4137
36732296	539	542	tau	Gene	4137
36732296	552	569	neurodegeneration	Disease	MESH:D019636
36732296	642	645	tau	Gene	4137
36732296	683	686	tau	Gene	4137
36732296	732	735	tau	Gene	4137
36732296	839	842	tau	Gene	4137
36732296	858	861	tau	Gene	4137
36732296	932	935	tau	Gene	4137
36732296	960	985	neurodegenerative disease	Disease	MESH:D019636
36732296	1050	1053	tau	Gene	4137
36732296	1089	1092	tau	Gene	4137
36732296	1147	1150	tau	Gene	4137
36732296	1180	1183	tau	Gene	4137
36732296	1225	1228	Tau	Gene	4137
36732296	1304	1307	tau	Gene	4137
36732296	1352	1355	tau	Gene	4137
36732296	1382	1385	tau	Gene	4137
36732296	1390	1399	poly(A)45	Chemical	-
36732296	1418	1440	Caenorhabditis elegans	Species	6239
36732296	1453	1456	tau	Gene	4137
36732296	1486	1506	neuronal dysfunction	Disease	MESH:D009461
36732296	1524	1527	tau	Gene	4137
36732296	1573	1592	Alzheimer's disease	Disease	MESH:D000544
36732296	1621	1624	tau	Gene	4137
36732296	1657	1660	tau	Gene	4137
36732296	1726	1737	tau lesions	Disease	MESH:C536599
36732296	1758	1767	tauopathy	Disease	MESH:D024801
36732296	1790	1794	mice	Species	10090
36732296	1834	1837	TRC	Gene	7183
36732296	1875	1880	human	Species	9606
36732296	1881	1892	tauopathies	Disease	MESH:D024801
36732296	1903	1922	Alzheimer's disease	Disease	MESH:D000544
36732296	1924	1954	progressive supranuclear palsy	Disease	MESH:D013494
36732296	1956	1981	corticobasal degeneration	Disease	MESH:D000088282
36732296	1987	2001	Pick's disease	Disease	MESH:D020774
36732296	2020	2056	ocular pharyngeal muscular dystrophy	Disease	MESH:D017246
36732296	2068	2086	tauopathy disorder	Disease	MESH:D024801
36732296	2146	2152	PABPN1	Gene	8106
36732296	2190	2193	tau	Gene	4137
36732296	2220	2225	human	Species	9606
36732296	2233	2236	Tau	Gene	4137
36732296	2256	2259	tau	Gene	4137
36732296	2309	2312	tau	Gene	4137
36732296	2376	2379	tau	Gene	4137
36732296	2426	2429	tau	Gene	4137
36732296	2456	2468	tau toxicity	Disease	MESH:C536599
36732296	2472	2491	tauopathy disorders	Disease	MESH:D024801
36732296	Association	MESH:D013494	7183
36732296	Association	MESH:D000088282	7183
36732296	Association	MESH:D000544	7183
36732296	Association	MESH:D019636	4137
36732296	Association	MESH:D013494	4137
36732296	Association	MESH:D024801	7183
36732296	Association	MESH:D020774	4137
36732296	Association	4137	8106
36732296	Association	MESH:D020774	7183
36732296	Association	MESH:C536599	4137
36732296	Association	MESH:D017246	4137
36732296	Association	MESH:D017246	8106
36732296	Association	MESH:D000088282	4137
36732296	Association	MESH:D024801	4137
36732296	Bind	4137	7183
36732296	Association	MESH:D009461	4137
36732296	Association	MESH:D000544	4137

